Clinical trial
Evaluation of Effectiveness and Safety of the Rituximab Immunotherapy Plus Insulin Therapy Compared to Insulin Therapy Alone in Adolescents With Recent-Onset Type 1 Diabetes Mellitus
NCT07041268 is registered in ClinicalTrials.gov with Pirogov Russian National Research Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Effectiveness and Safety of the Rituximab Immunotherapy Plus Insulin Therapy Compared to Insulin Therapy Alone in Adolescents With Recent-Onset Type 1 Diabetes Mellitus
- Lead sponsor
- Pirogov Russian National Research Medical University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 19, 2024
- Completion date
- March 31, 2028
- Enrollment
- 116 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.